Ernest Nadal

机构：Bellvitge University Hospital, Institut d'Investigació Biomédica de Bellvitge, Institut Català d'Oncologia, Spanish Ovarian Cancer Research Group · ORCID：0000-0002-9674-5554

发表论文 571 篇 · 总被引 11231 次 · h-index 56

代表论文

EML4−ALK Mediates Resistance to KRASG12C Inhibition and Induces an Oncogenic Dependency by Rewiring Signaling through the Wild-Type RAS Pathway (2026 · Cancer Discovery · 被引 1)
Neo-DIANA: descriptive results of a prematurely terminated phase II trial of neoadjuvant atezolizumab, chemotherapy and bevacizumab in resectable EGFR-mutated NSCLC (2026 · Translational Lung Cancer Research)
Targeting KRAS codon 13 mutations using direct combination approaches in non-small cell lung cancer (2026 · Cancer Discovery)
Figure S9 from Decoding B-cell Signatures of Complete Pathologic Response to Perioperative Chemoimmunotherapy in Non–Small Cell Lung Cancer (2026)
Figure S1 from Decoding B-cell Signatures of Complete Pathologic Response to Perioperative Chemoimmunotherapy in Non–Small Cell Lung Cancer (2026)
Figure S4 from Decoding B-cell Signatures of Complete Pathologic Response to Perioperative Chemoimmunotherapy in Non–Small Cell Lung Cancer (2026)